Cargando…
COVID-19 and Alzheimer’s Disease
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have...
Autores principales: | Ciaccio, Marcello, Lo Sasso, Bruna, Scazzone, Concetta, Gambino, Caterina Maria, Ciaccio, Anna Maria, Bivona, Giulia, Piccoli, Tommaso, Giglio, Rosaria Vincenza, Agnello, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997244/ https://www.ncbi.nlm.nih.gov/pubmed/33673697 http://dx.doi.org/10.3390/brainsci11030305 |
Ejemplares similares
-
The Role of Vitamin D as a Biomarker in Alzheimer’s Disease
por: Bivona, Giulia, et al.
Publicado: (2021) -
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021) -
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases
por: Bivona, Giulia, et al.
Publicado: (2022) -
Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
por: Lo Sasso, Bruna, et al.
Publicado: (2021) -
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives
por: Bivona, Giulia, et al.
Publicado: (2023)